UConn Health
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, UConn Health sits in the top decile of US sponsors by registered trial count (#168 of 15,742 sponsors by registered trial count).
UConn Health: 178 sponsored US clinical trials, 19 recruiting.
UConn Health sponsors 178 registered US clinical trials on ClinicalTrials.gov, 19 of them currently recruiting, and 132 completed. 25 of these trials are in Phase 3-4 (later-stage) and 23 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alcoholism, with 5 trials.
Top-decile sponsor footprint
UConn Health ranks in the top decile of sponsors by registered trial count (#168 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
132 of 151 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
178 total, page 4 of 4
Vouchers vs. Prizes for Cocaine-Dependent Methadone Patients - 2
NCT00249535
Mothers Overcoming and Managing Stress
NCT00751244
Cognitive Behavioral Treatments for Pathological Gambling
NCT00618462
Impact of a Brief Motivational Interview on Drinking Behaviors of At Risk Drinkers Screened in the Emergency Room
NCT00183183
Sertraline Pharmacotherapy for Alcoholism Subtypes
NCT00368550
Training Therapists to Administer Contingency Management-Patient Phase - 3
NCT00249418
Smoking Cessation in Substance Abuse Treatment Patients: A Feasibility Study
NCT00408265
Therapists to Administer Contingency Management-Therapist Phase - 1
NCT00249626
Enhanced and Attendance-based Prize CM in Community Settings
NCT00606853
Brief Treatment for Temporomandibular Pain
NCT00067366
Contingency Management for Chronic Recidivist Alcohol-Dependent Patients
NCT00408161
Cox-2 Inhibition in Radiation-induced Oral Mucositis
NCT00698204
Targeted Naltrexone for Problem Drinkers
NCT00369408
Lower-Cost Contingency Management in a Group Setting - 1
NCT00249600
Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer
NCT00859027
Cognitive-Behavioral Treatment of Gambling
NCT00118391
Effectiveness of SisterTalk Hartford for Weight Loss Among African-American Women
NCT01282749
The Provider and Organization in Asthma Guidelines
NCT00345514
Persantine: Variation in Response Trial
NCT00763009
Network Support for Treatment of Alcohol Dependence
NCT00845208
An Evaluation of the SOS (Suicide Prevention) Program
NCT00387855
Better Pediatric Asthma Outcomes Through Chronic Care
NCT00355069
Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
NCT00030303
Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70
NCT00027131
Gambling and Brief Interventions
NCT00183599
Cognitive Behavioral Therapy for Treatment of Pathological Gambling
NCT00158314
Naltrexone for Relapse Prevention
NCT00000442
Naltrexone for Early Problem Drinkers
NCT00000455
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 8 |
| Phase 2 | 15 |
| Phase 3 | 5 |
| Phase 4 | 20 |
Therapeutic Areas
What is open in the UConn Health pipeline
19 recruiting of 178 indexed (11% open); 132 completed (74%).
Phase mix: 25 late (III/IV) vs 23 early (I/II) (balanced across stages).
Top condition: Alcoholism (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
UConn Health: open-pipeline peers nationwide
Peers matched on 178 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
UConn Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 178 trials (± recruiting share)
- Baylor Research Institute · 180 trials · 17% recruiting
- Abbott · 181 trials · 0% recruiting
- Albert Einstein College of Medicine · 175 trials · 11% recruiting
- ViiV Healthcare · 182 trials · 4% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Hartford Hospital · 11% recruiting · 75 trials
- Tufts Medical Center · 11% recruiting · 169 trials
- CAMC Health System · 11% recruiting · 28 trials
- Carnegie Mellon University · 11% recruiting · 37 trials
Related
What to do with this UConn Health page
178 registered trials is a research-attention snapshot, not an endorsement of UConn Health or any single study.
- 19 of UConn Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alcoholism is the condition UConn Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcoholism trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
UConn Health pipeline card: 178 registered trials from official public datasets.Report a data error.